Adaptimmune
Develops therapies to treat cancer
Adaptimmune has raised €79M across 1 funding round from 4 investors, most recently a Series A round in Sep 2014. Based in Milton, UK; founded 2008; active in Healthtech. Data as of 4 Nov 2026.
Total raised
€79M
€78,859,569
Funding rounds
1
Investors
4
distinct backers
Active since
2014-09
latest 2014-09
Funding by year
EUR raised per yearAdaptimmune — funding by year — interactive chart.
Data table
| Adaptimmune — funding by year | |
|---|---|
| 2014 | €79M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2014-09-01 | Series A | €79M | New Enterprise Associates,Novo A,S,Wellington Partners | View deal → |
Similar companies
same sector, similar size- Benevolent€80MUK · Healthtech
- Cell Medica€99MUK · Healthtech
- Kymab€98MUK · Healthtech
- Trogenix€80MUK · Healthtech
- Maxion Therapeutics€83MUK · Healthtech
- CoMind€86MUK · Healthtech
Global coverage: FundingData